Discovering novel Cathepsin L inhibitors from natural products using artificial intelligence
Source check: Needs source check. Not independent scientific confirmation.
Finding: Discovering novel Cathepsin L inhibitors from natural products using artificial intelligence. Screened natural products for Cathepsin L inhibitors; 150 molecules were selected for testing. 36 of 150 inhibited CTSL by more than 50 percent at 100 uM; 13 exceeded 90 percent; plumbagin and beta-lapachone were most potent. Evidence limits: Only enzyme assays and MD; cellular or in vivo effects and hit-rate against a random baseline not assessed. Reviewed from Europe PMC abstract only.
Technology: Deep learning model with molecular docking
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- Screened natural products for Cathepsin L inhibitors; 150 molecules were selected for testing.
- Test and result
- 36 of 150 inhibited CTSL by more than 50 percent at 100 uM; 13 exceeded 90 percent; plumbagin and beta-lapachone were most potent.
- Limitation / still unknown
- Only enzyme assays and MD; cellular or in vivo effects and hit-rate against a random baseline not assessed.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://europepmc.org/article/MED/39006920
Needs source check · editorial details
The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review scope and date are not recorded; source checked does not establish full-text review.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.